Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data
to obtain or maintain patent or other proprietaryintellectual property protection; competition in general; increasedgovernment industry and general public pricing pressures;unexpected clinical trial results including additional analysis ofclinical data or new clinical data; unexpected regulatory actionsor delays or government regulation generally; and other risks andfactors referred to i
to obtain or maintain patent or other proprietary
intellectual property protection; competition in general; increased
government, industry, and general public pricing pressures;
unexpected clinical trial results, including additional analysis of
clinical data, or new clinical data; unexpected regulatory actions
or delays or government regulation generally; and other risks and
factors referred to in Novartis AG's current Form 20-F on file with
the US Securities and Exchange Commission. Should one or more of
these risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially
from those anticipated, believed, estimated or expected. Novartis
is providing the information in this press release as of this date
and does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new
information, future events or otherwise.
About Novartis
Novartis AG (NYSE: NVS) is a world leader in
offering medicines to protect health, cure disease and improve
well-being. Our goal is to discover, develop and successfully
market innovative products to treat patients, ease suffering and
enhance the quality of life. We are strengthening our
medicine-based portfolio, which is focused on strategic growth
platforms in innovation-driven pharmaceuticals, high-quality and
low-cost generics, human vaccines and leading self-medication OTC
brands. Novartis is the only company with leadership positions in
these areas. In 2006, the Group's businesses achieved net sales of
USD 37.0 billion and net income of USD 7.2 billion. Approximately
USD 5.4 billion was invested in R&D. Headquartered in Basel,
Switzerland, Novartis Group companies employ approximately 100,000
associates and operate in over 140 countries around the world. For
more information, please visit
Page: 1 2 3 4 5 6 7 8 Related medicine technology :1.
ApoCells Cancer Predictive Index Helps Oncologists Select the Most
Effective Targeted Drug Therapy2.
Study Suggests Invega Helps Patients With Schizophrenia Maintain
Symptom Control3.
International ENDORSE Study Shows That the Majority of Hospitalized
Patients Surveyed are at Risk for VTE and Many do not Receive
Recommended VTE prophylaxis4.
Hematology Analyzers Simple, Sophisticated Technology Serving All Patients5.
Actemra (tocilizumab) Third Phase III Study Results Show
Significant Improvement in Symptoms of Patients with Rheumatoid
Arthritis6.
Phase III Trial Results Show Superiority of Rivaroxaban over
Enoxaparin for the Prevention of Venous Thromboembolism in Patients
Undergoing Knee Replacement Surgery7.
New Study Shows That Extending Prophylaxis With Clexane / Lovenox
(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10
Days for Reducing the Risk of Venous Thromboembolism (VTE) in
Acutely ill Medical Patients With Reduced Mobility8.
Phase III Trial Results Show Superiority of Rivaroxaban over
Enoxaparin for the Prevention of Venous Thromboembolism in Patients
Undergoing Knee Replacement Surgery9.
Genzyme Announces Data from First Phase 3 Study of Tolevamer in
Patients with C. difficile Associated Diarrhea10.
TMC125 Showed Significant Virologic Response at Week 24 in
Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3
Trials11.
Study Shows Ixabepilone Demonstrated Clear Activity in Patients
with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,
and Capecitabine
(Date:11/25/2009)...ewswire/-- FromNovember16-18,Phonak,theleadingmanu...econdeditionoftheHearingCareforAdultsConference,fo...ferencebroughttogetherleadingexpertsinagingandaudi...workeverydaywitholderpeoplewithhearinglossforanopp...rchandtrendsinhearingcareforolderpeople. ,, We...
(Date:11/25/2009)...heFDAgrantedtraditionalapprovalforINTELENCE®(...taseinhibitor(NNRTI).INTELENCEistheonlyNNRTIspecif...whoareexperiencingvirologicfailurewithHIV-1strains...s.Thetraditionalapprovalisbasedon48-weekdatafromtw...rrentlymarketedintheU.S.byTibotecTherapeutics,adiv...
(Date:11/25/2009)...wswire/--RemediumTechnologiesInc.,acompanydevelopi...nfirstprizeand$10,000intheMostPromisingSecurityIde...fficialsannouncetoday. ,, Selectedfrommorethan1...heirinventionattheGSCSecuritySummitconferencehelda...mediumtechnologies.com )isdevelopingahigh-pressure...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster 12804 1Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster 12804 2Teens With Eating Disorders Benefit From Parents Help 50161 1Teens With Eating Disorders Benefit From Parents Help 50161 2Teens With Eating Disorders Benefit From Parents Help 50161 3Align Technology Announces Jury Verdict in Patent Litigation With Ormco Corporation 50156 1Align Technology Announces Jury Verdict in Patent Litigation With Ormco Corporation 50156 2(Date:11/25/2009)...wswire-USNewswire/--WhenmostpeopleheartheacronymTM...ivepatientsthehelptheyneed.TMJstandsfortheTemporal...acts/connectswithyourskull(temporalbone). ,, Th...painwithchewing,clickingorpoppingofthejaw.Butmanyo...:headaches,fatigue,sleepdisturbances,irritability,...
(Date:11/25/2009)...5/PRNewswire/-SentinelleMedicalInc.,aleadingmanufa...areandCalgaryScientificInc.,aleadingproviderofsoft...ofAegis(TM)Breast4DAdvancedVisualizationsoftware. ...ootprintWebclientbasedmedicalimagingofferinginthem...forzero-footprintaccess-requiringnosoftwaredownloa...
(Date:11/25/2009).../PRNewswire-USNewswire/--AnarticlebyJanetWoodcock,...esearch,titled"ADifficultBalance-PainManagement,Dr...TheNewEnglandJournalofMedicine. ,, (Logo: http:...,, Inthearticle,WoodcockdiscussesFDAeffortstost...honeeditandmanagingtherisksposedbyvariousanalgesic...
(Date:11/25/2009)...ents,Business,andPressJoinEfforttoEducate ,, M...ain,theNationalBipolarFoundationandtheMedicAlertFo...lStable"program,whichisnowbeingwidelyacceptedasapr...theNationalBipolarFoundationreceivedaproclamationo....GovernorofLouisianaMitchLandrieu.TheNationalBipol...
(Date:11/25/2009)... grew out of a collaboration between UCLA engineer...he nearly 10 million Americans who suffer from per...rdening of the arteries, peripheral arterial disea...ch narrowed arteries reduce blood flow to the limb...ular disease, heart attack and stroke, and its pro...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4... Premised upon totally hassle-free virtual shopp...ched to the online scene to cater to people who wa...g moments. Pampering one,s self is a most deserve...g, www.personalcaredeals.com ] was recently launc...
... The physician shortage in the United States is ...feature article in the August issue of the Jackson... Atlanta, GA (PRWEB) September 10, 2008 -- T....jacksoncoker.com/newsletter/Long_8282008.aspx [J...
... A national database of free clinics is now avai...]], a web-based resource of programs that assist w...ver 2,100 free or low-cost clinics and is the most...ce programs, disease based assistance programs and...
... fewer smokers, MINNEAPOLIS, Sept. 10 Findings f...S), released today, show that Minnesota,is making ...survey --,conducted by ClearWay Minnesota(SM), Blu...17 percent. That figure is,down approximately 5 pe...
...0, 2008)In recent years, private equity investors ...ment opportunities. Spurred by investigative repor...worsened quality of care, many companies have foun...g homesmany of which result in administrative and ...
... that urgent endoscopy for UGIB should be performe...in this period of time, it is still unclear whethe...ithin 2 hour or in a more delayed interval, such ...ublished on August 28, 2008 in the World Journal ...
Other Medicine News:Health News:A One-Stop Online Shop For Personal Pampering Needs 2Health News:A One-Stop Online Shop For Personal Pampering Needs 3Health News:Addressing the Physician Shortage--Who's Doing What? 2Health News:Addressing the Physician Shortage--Who's Doing What? 3Health News:Addressing the Physician Shortage--Who's Doing What? 4Health News:Addressing the Physician Shortage--Who's Doing What? 5Health News:Addressing the Physician Shortage--Who's Doing What? 6Health News:Urgently Needed Database Now Available for People Who Cannot Afford Health Care at NeedyMeds.com 2Health News:Smoking Rate Falls Dramatically Among Minnesotans 2Health News:Smoking Rate Falls Dramatically Among Minnesotans 3Health News:Smoking Rate Falls Dramatically Among Minnesotans 4Health News:Private equity companies purchase nursing homes, but care does not suffer 2Health News:Private equity companies purchase nursing homes, but care does not suffer 3... particular challenge in transseptal left heart ca...th must be exchanged for a sheath with an alternat.... Traditionally, such an exchange has required a r...tient. Biosense Webster has overcome this problem ...
Response™ Catheter
Fast-Cath™ Guiding Introducers
Lumenis 1000 Integrated Slit Lamp
Medicine Products: